4//SEC Filing
PROTALEX INC 4
Accession 0001140361-15-026875
CIK 0001099215operating
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 12:51 PM ET
Size
10.8 KB
Accession
0001140361-15-026875
Insider Transaction Report
Form 4
PROTALEX INCPRTX
WARSHAW KIRK M
Chief Financial Officer
Transactions
- Award
Option
2015-07-01+250,000→ 250,000 totalExercise: $5.41From: 2015-07-01Exp: 2020-07-01→ Common Stock (250,000 underlying)
Holdings
- 350,000
Option
Exercise: $1.05Exp: 2023-05-21→ Common Stock (350,000 underlying) - 250,000
Option
Exercise: $1.01Exp: 2021-11-01→ Common Stock (250,000 underlying) - 750,543
Option
Exercise: $0.25Exp: 2019-12-29→ Common Stock (750,543 underlying) - 100,000
Option
Exercise: $6.00From: 2014-11-04Exp: 2024-11-04→ Common Stock (100,000 underlying)
Footnotes (4)
- [F1]Granted on May 22, 2013 (the "Grant Date"), this option is exercisable to acquire 50% of the underlying shares on the Grant Date and 100% of the underlying shares on the six-month anniversary of Grant Date.
- [F2]Immediately.
- [F3]Adjusted to reflect a 1 for 5 reverse split of the issuer's outstanding common stock on December 8, 2010.
- [F4]Granted on July 1, 2015 (the "July Grant Date"), this option is exercisable to acquire 50% of the underlying shares on the Grant Date and 100% of the underlying shares on the 1st anniversary of July Grant Date.
Documents
Issuer
PROTALEX INC
CIK 0001099215
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001099215
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 12:51 PM ET
- Size
- 10.8 KB